Chinese Journal of Tissue Engineering Research ›› 2014, Vol. 18 ›› Issue (47): 7566-7572.doi: 10.3969/j.issn.2095-4344.2014.47.005

Previous Articles     Next Articles

Calcium phosphate bone cement and biodegradable mesh-like microporous balloon for vertebroplasty

Xie Zhi-yong1, Liu Xun-wei1, Zhong Jian2, Wei Dai-xu2, Ye Yong1, Du Yan-xia1, Sun Gang1   

  1. 1Department of Medical Image, Jinan Military General Hospital, Jinan 250031, Shandong Province, China
    2National Engineering Research Center for Nanotechnology (NERCN), Shanghai 200241, China
  • Revised:2014-09-19 Online:2014-11-19 Published:2014-11-19
  • Contact: Sun Gang, M.D., Chief physician, Professor, Doctoral supervisor, Department of Medical Image, Jinan Military General Hospital, Jinan 250031, Shandong Province, China
  • About author:Xie Zhi-yong, Associate chief physician, Department of Medical Image, Jinan Military General Hospital, Jinan 250031, Shandong Province, China
  • Supported by:

    the National High Technology Research and Development Program of China (863 Program), No. 2013AA032203; the National Natural Science Foundation of China, No. 51073173

Abstract:

BACKGROUND: In vitro experiments have demonstrated that the biodegradable mesh-like microporous balloon made of macromolecular materials has obvious advantage of anti-leakage, which is capable of maintaining calcium homeostasis, has no inhibitory effects on cell growth and on microscopic interdigitation formation between new bone and bone cement.
OBJECTIVE: To evaluate the therapeutic effects of biodegradable mesh-like microporous balloon with calcium bone cement on vertebral fractures based on animal experiments.
METHODS: The fracture model was established in 48 New Zealand rabbits, in which a bone drill was introduced after successful puncture at sites near left low extremity of the femur. These rabbit models were randomized into two groups: experimental group with calcium phosphate bone cement and biodegradable mesh-like microporous balloon and control group only with calcium phosphate bone cement. Clinical parameters such as blood cell count, biochemistry, and CT/X ray were examined at 1, 3 and 6 months after implantation of the balloon and bone cement. After that, the specimens were fixed for pathological analysis.
RESULTS AND CONCLUSION: The operation was performed under general anesthesia with no eventful infusion of bone cement. The expansion of balloon was satisfactory without definite extravasation of bone cement in the experimental group. In the control group, cement diffusion was found with pulmonary embolism occurring in three New Zealand rabbits. No statistical significance for blood cell counts and biochemistry was found between pre- and postoperation or between two groups. The materials in the two groups had favorable biocompatibility with injured bones without obvious immunological response. In the experimental group, the balloon wall was thinned and partial bone tissues grew into the cement at 1 month; at 3 months, a large amount of bone tissues grew into the cement and cement volume diminished; at 6 months, the balloon disappeared and only a small amount of cement left in the bone tissues. In the control group, it was difficult to determine when the cement degraded. The biodegradable mesh-like microporous balloon combined with calcium bone cement is superior to bone cement alone in the management of vertebral fractures.


中国组织工程研究杂志出版内容重点:生物材料;骨生物材料; 口腔生物材料; 纳米材料; 缓释材料; 材料相容性;组织工程


全文链接:

Key words: nanofibers, fractures, biocompatible materials

CLC Number: